TYK Medicines (HKG:2410) obtained approval from the Listing Committee of the Hong Kong Stock Exchange to list over 4.6 million shares to be converted under the firm's Hong Kong-listed share full circulation.
The shares, held by one shareholder, represent 1.21% of the pharmaceutical company's issued share capital, according to a Thursday Hong Kong bourse filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.